Sensus Healthcare (SRTS) Common Equity (2015 - 2026)

Sensus Healthcare's Common Equity history runs 12 years deep, the most recent figure standing at $45.5 million for Q1 2026.

• On a quarterly basis, Common Equity fell 14.13% year-over-year to $45.5 million in Q1 2026; TTM through Mar 2026 was $45.5 million, a 14.13% decrease from a year earlier, with the FY2025 full-year figure at $48.1 million, down 13.84% from the prior year.
• Common Equity fell to $45.5 million in Q1 2026 per SRTS's latest filing, from $48.1 million in the prior quarter.
• Across five years, Common Equity topped out at $55.8 million in Q4 2024 and bottomed at $42.5 million in Q1 2022.
• The 5-year median for Common Equity is $48.1 million (2025), against an average of $49.0 million.
• Across the five-year window, Common Equity surged 128.68% in 2022 and retreated 14.13% in 2026, its largest moves.
• Year by year, Common Equity stood at $48.1 million in 2022, then advanced by 1.61% to $48.8 million in 2023, then advanced by 14.3% to $55.8 million in 2024, then fell by 13.84% to $48.1 million in 2025, then declined by 5.31% to $45.5 million in 2026.
• Per Business Quant, the three latest SRTS Common Equity figures stand at $45.5 million (Q1 2026), $48.1 million (Q4 2025), and $51.2 million (Q3 2025).